vs
Pediatrix Medical Group, Inc.（MD）与Reddit, Inc.（RDDT）财务数据对比。点击上方公司名可切换其他公司
Reddit, Inc.的季度营收约是Pediatrix Medical Group, Inc.的1.3倍（$663.0M vs $493.8M），Reddit, Inc.净利率更高（30.8% vs 6.8%，领先23.9%），Reddit, Inc.同比增速更快（69.0% vs -1.7%），过去两年Reddit, Inc.的营收复合增速更高（53.6% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台，注册用户可发布链接、文字帖、图片、视频等各类内容，其他用户可对内容进行点赞或点踩，内容按主题归类到用户创建的子板块中，获赞更高的内容会排在板块前列，热度足够的内容还将展示在全站首页。
MD vs RDDT — 直观对比
营收规模更大
RDDT
是对方的1.3倍
$493.8M
营收增速更快
RDDT
高出70.7%
-1.7%
净利率更高
RDDT
高出23.9%
6.8%
两年增速更快
RDDT
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $663.0M |
| 净利润 | $33.7M | $204.0M |
| 毛利率 | — | 100.0% |
| 营业利润率 | 9.9% | 0.0% |
| 净利率 | 6.8% | 30.8% |
| 营收同比 | -1.7% | 69.0% |
| 净利润同比 | 10.5% | 680.0% |
| 每股收益（稀释后） | $0.40 | $1.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDRDDT
| Q1 26 | — | $663.0M | ||
| Q4 25 | $493.8M | $725.6M | ||
| Q3 25 | $492.9M | $584.9M | ||
| Q2 25 | $468.8M | $499.6M | ||
| Q1 25 | $458.4M | $392.4M | ||
| Q4 24 | $502.4M | $427.7M | ||
| Q3 24 | $511.2M | $348.4M | ||
| Q2 24 | $504.3M | $281.2M |
净利润MDRDDT
| Q1 26 | — | $204.0M | ||
| Q4 25 | $33.7M | $251.6M | ||
| Q3 25 | $71.7M | $162.7M | ||
| Q2 25 | $39.3M | $89.3M | ||
| Q1 25 | $20.7M | $26.2M | ||
| Q4 24 | $30.5M | $71.0M | ||
| Q3 24 | $19.4M | $29.9M | ||
| Q2 24 | $-153.0M | $-10.1M |
毛利率MDRDDT
| Q1 26 | — | 100.0% | ||
| Q4 25 | — | 91.9% | ||
| Q3 25 | — | 91.0% | ||
| Q2 25 | — | 90.8% | ||
| Q1 25 | — | 90.5% | ||
| Q4 24 | — | 92.6% | ||
| Q3 24 | — | 90.1% | ||
| Q2 24 | — | 89.5% |
营业利润率MDRDDT
| Q1 26 | — | 0.0% | ||
| Q4 25 | 9.9% | 31.9% | ||
| Q3 25 | 13.8% | 23.7% | ||
| Q2 25 | 12.8% | 13.6% | ||
| Q1 25 | 7.0% | 1.0% | ||
| Q4 24 | 7.8% | 12.4% | ||
| Q3 24 | 6.6% | 2.0% | ||
| Q2 24 | -31.3% | -11.0% |
净利率MDRDDT
| Q1 26 | — | 30.8% | ||
| Q4 25 | 6.8% | 34.7% | ||
| Q3 25 | 14.5% | 27.8% | ||
| Q2 25 | 8.4% | 17.9% | ||
| Q1 25 | 4.5% | 6.7% | ||
| Q4 24 | 6.1% | 16.6% | ||
| Q3 24 | 3.8% | 8.6% | ||
| Q2 24 | -30.3% | -3.6% |
每股收益（稀释后）MDRDDT
| Q1 26 | — | $1.01 | ||
| Q4 25 | $0.40 | $1.24 | ||
| Q3 25 | $0.84 | $0.80 | ||
| Q2 25 | $0.46 | $0.45 | ||
| Q1 25 | $0.24 | $0.13 | ||
| Q4 24 | $0.37 | $4.76 | ||
| Q3 24 | $0.23 | $0.16 | ||
| Q2 24 | $-1.84 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $1.4B |
| 总债务越低越好 | $570.5M | — |
| 股东权益账面价值 | $865.9M | $3.2B |
| 总资产 | $2.2B | $3.5B |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资MDRDDT
| Q1 26 | — | $1.4B | ||
| Q4 25 | $375.2M | $953.6M | ||
| Q3 25 | $340.1M | $911.7M | ||
| Q2 25 | $224.7M | $734.1M | ||
| Q1 25 | $99.0M | $635.7M | ||
| Q4 24 | $229.9M | $562.1M | ||
| Q3 24 | $103.8M | $515.9M | ||
| Q2 24 | $19.4M | $468.0M |
总债务MDRDDT
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益MDRDDT
| Q1 26 | — | $3.2B | ||
| Q4 25 | $865.9M | $2.9B | ||
| Q3 25 | $890.7M | $2.6B | ||
| Q2 25 | $833.8M | $2.4B | ||
| Q1 25 | $789.2M | $2.2B | ||
| Q4 24 | $764.9M | $2.1B | ||
| Q3 24 | $732.5M | $2.0B | ||
| Q2 24 | $706.5M | $1.9B |
总资产MDRDDT
| Q1 26 | — | $3.5B | ||
| Q4 25 | $2.2B | $3.2B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.0B | $2.4B | ||
| Q4 24 | $2.2B | $2.3B | ||
| Q3 24 | $2.1B | $2.2B | ||
| Q2 24 | $2.0B | $2.1B |
负债/权益比MDRDDT
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | — |
| 自由现金流经营现金流 - 资本支出 | — | $311.0M |
| 自由现金流率自由现金流/营收 | — | 46.9% |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.39× | — |
| 过去12个月自由现金流最近4个季度 | — | $868.6M |
8季度趋势，按日历期对齐
经营现金流MDRDDT
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $266.8M | ||
| Q3 25 | $137.3M | $185.2M | ||
| Q2 25 | $137.2M | $111.3M | ||
| Q1 25 | $-117.5M | $127.6M | ||
| Q4 24 | $133.0M | $90.0M | ||
| Q3 24 | $91.8M | $71.6M | ||
| Q2 24 | $107.0M | $28.4M |
自由现金流MDRDDT
| Q1 26 | — | $311.0M | ||
| Q4 25 | — | $263.6M | ||
| Q3 25 | — | $183.1M | ||
| Q2 25 | — | $110.8M | ||
| Q1 25 | — | $126.6M | ||
| Q4 24 | — | $89.2M | ||
| Q3 24 | — | $70.3M | ||
| Q2 24 | — | $27.2M |
自由现金流率MDRDDT
| Q1 26 | — | 46.9% | ||
| Q4 25 | — | 36.3% | ||
| Q3 25 | — | 31.3% | ||
| Q2 25 | — | 22.2% | ||
| Q1 25 | — | 32.3% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | — | 20.2% | ||
| Q2 24 | — | 9.7% |
资本支出强度MDRDDT
| Q1 26 | — | — | ||
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% |
现金转化率MDRDDT
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 1.06× | ||
| Q3 25 | 1.91× | 1.14× | ||
| Q2 25 | 3.49× | 1.25× | ||
| Q1 25 | -5.66× | 4.88× | ||
| Q4 24 | 4.36× | 1.27× | ||
| Q3 24 | 4.72× | 2.40× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
RDDT
暂无分部数据
